Sample size
Blood samples were collected between August and October 2013 from the Bolu city center and the Gerede, Mudurnu, Göynük, Yeniçağa, Seben, Mengen, Dörtdivan, and Kıbrıscık districts to investigate the seropositivity rates of Lyme disease. A stratified sampling method was used to determine the study population. The sample size was calculated using the following formula:
In this formula, N represents the population size (the population in the province of Bolu is 276,500), t is a constant (1.96), p is the a priori assumption of the population parameter (0.15 according to the results of recent studies in Turkey), q is equal to 1 -p, and d is the margin of error (0.05%). The number of research samples (n) was defined as 196. The sample size was compared for each district according to population density.
Questionnaire
Each participant was asked about demographic information, place of residence, any clinical symptoms of tick exposure, where they spent the summer, and whether they dealt with agriculture.
Laboratory tests
Blood samples of at least 5 mL were taken from patients and were transferred in appropriate circumstances to the microbiology laboratory of Abant İzzet Baysal University, Faculty of Medicine. Blood samples were centrifuged at 4000 rpm for 10 min and the obtained sera were stored at -20 °C until analysis. First, a total of 196 blood samples were investigated for diagnosis of Lyme disease by the ELISA screening method. A commercial ELISA kit (Euroimmun, Germany) was used to investigate IgM against B. burgdorferi, B. afzelii, and B. garinii and IgG antibody levels against B. burgdorferi, B. afzelii, B. garinii, and Borrelia vlsE antigens. Results were evaluated semiquantitatively. At the end of the study, positive and borderline IgG and IgM results were included in the second round of study. ELISA serum samples with positive or borderline results were confirmed using the Borrelia EUROLINE RN-AT WB kit (Euroimmun). WB IgG and IgM results were evaluated in accordance with the criteria in the kit. ELISA and WB tests were performed according to the manufacturer's recommendations.
Statistical analysis
Data analysis was performed using SPSS 17.0 for Windows. Descriptive statistics were expressed as numbers and percentages. Differences between groups in terms of categorical variables were analyzed using the chi-square and Fisher exact tests. The results were evaluated at a 95% confidence interval and P < 0.05 was accepted as significant.
Results
The study included 196 individuals; 61.2% of them were female and 38.8% were male.
According to the ELISA test results 14.8% were positive (29/196) and 1.0% were borderline (2/196) Table 3 . No statistically significant difference was found between seropositivity rates and survey data.
Demographic characteristics of B. burgdorferi serologypositive cases and serology results are listed in Table 4 .
Discussion
Lyme disease is endemic to temperate regions of the northeastern United States and Central and East Europe. Since becoming a nationally notifiable disease in the United States in 1991, a total of 248,074 Lyme disease cases were reported to the Centers for Disease Control. During Borderline (n = 2) 2 0 (10) . It was reported in Turkey that Lyme positivity was higher in women in Samsun (11) . In our study, the seropositivity rate was higher in women (8.3%) and 50% of them were in the age group of 40 to 60 years. As women are more involved in animal care and work in the fields more compared to men, their risk of contact with ticks is increased and we think this affects the emergence of high seropositivity among females.
Age-related attack rates of Lyme disease show bimodal distribution according to a study conducted in the United States. The first peak is from 5 to 9 years (8.9 cases per 100,000 people) and the second most common age range is 55-59 years (7.8 cases per 100,000 people) (5) . Considering the age group in our study, the highest seropositivity rate was observed in the age group of 40-60 years (10%).
The Lyme disease agents, Ixodes spp. ticks, prefer forested areas especially and the edges of lakes and rivers (12) . In rural areas, the risk of contact with ticks is greater. In a study conducted in Spain in 2004, Lyme seropositivity was 3.45%, with 4.19% reported in rural areas and 2.82% urban areas (13) . In our study, higher seropositivity was determined among those living in rural areas (11.1% vs. 5.2%, respectively). People who spent summers in rural areas were also found to have higher seropositivity (10.2%) In our survey, the seropositivity rate was higher in people who were illiterate (10.0%). Increasing levels of education increase the level of knowledge in the fight against ticks and these people are less likely to live in rural areas or are less likely to be engaged in agriculture.
In North America and Europe, the nymphal stage of the tick especially is responsible for the emergence of Lyme disease. Tick exposure is less likely to be noticed as infected ticks in the nymph stage are small in size, and the bite does not cause pain and itching. A study in the United States showed that only 25% remembered a history of tick bite (14) . In our study, tick exposure was stated only for two of 16 patients seropositive for Lyme disease. This suggests that tick exposure may not be remembered.
Development of Lyme disease after tick exposure and the appearance of symptoms varies between regions. In England, Lyme disease risk varies between 1.2% and 3.7% after tick exposure (6) . Tick exposure was remembered by nine (4.6%) of 196 people who participated in the study and only two people (1.0%) had seropositivity. The reasons for not detecting seropositivity in people who have tick exposure are thought to be that ticks may not carry Lyme factors or recent tick exposure (<1 week) such that adequate antibody response has not yet occurred.
Due to direct contact with ticks, dealing with agriculture is a risk factor for B. burgdorferi infection. A study conducted in Samsun determined that the positive rate was high in those dealing with agriculture (11). In our study, the seropositivity rate was higher in people who dealt with agriculture.
The ELISA serologic method is recommended as a screening test in epidemiological studies (15) . Reagent antigens used in the ELISA kit cannot be standardized so discrepancy may be found between the results obtained in the study. It is reported that vlsE surface protein has the highest sensitivity among recombinant antigens. The presence of antibodies against the vlsE immunodominant antigen is of great importance in the serological diagnosis of Lyme infection (16, 17) . In our study, both ELISA and WB tests included the vlsE recombinant antigen.
Güner et al. determined 98.8% to 100% similarity with genotypes of Europe (18) . Thus, they proved that the antigen used in diagnostic kits imported from Europe may be used in the laboratory diagnosis of Lyme disease in Turkey. In our study, ELISA and WB kits used the antigen of the European strain. Studies indicate that if the immunoblotting assay includes OspC antigens to detect IgM and vlsE antigen to detect IgG, the specificity of the diagnostic test is increased (15, 17) . In our study, in the WB test, the number of OspC antigen bands (other bands: p39, vlsE) in IgMpositive patients and the number of vlsE antigen bands in IgG-positive patients was seen to be more positive (other bands: OspC, p39, p83, p58, p21, p20, p19, and p18).
In a study conducted in Poland in 2008, Lyme seropositivity was 6% with the immunoblot method in healthy people living in urban areas and people working in rural areas were identified to have 33% seropositivity (19) . In 2001, the seroprevalence of B. burgdorferi was 4.3% in healthy blood donors and 9.3% in forestry workers according to Hristea et al. (20) . In a study conducted in Italy in 2005, 7.8% were positive for B. burgdorferi antibodies in the risk group and 4.9% in the control group according to ELISA, while with the immunoblot method these values were 7.03% and 3.56%, respectively (21) . In a study conducted in healthy people in Poland using the ELISA method, seropositivity ranged from 11% to 13% (22) .
Several studies have been conducted to determine Lyme seropositivity in Turkey. In 1990, the first reports of Lyme cases were reported from İzmir and Trabzon (1). In 1995, seropositivity was determined as 35.9% by ELISA in Antalya (7) . Studies done in Ankara using ELISA found that seropositivity was 13% in patients and 7.8% in the general population in 1999 (9) . In 2001 in studies done in Denizli, Trabzon, and Isparta, seropositivity was found by ELISA as 18.9%, 6.6%, and 17.07%, respectively (8, 23, 24) . In 2008 in a study in Düzce, seropositivity was determined in the risk groups as 10.9% with ELISA and as 1.1% with WB (2). In the same study, although there was a history of tick exposure of 51.9%, B. burgdorferi sensu lato infection was reported to be rare in the area. A study conducted in the Van region in 2008 found that the seropositivity rate was 6.3% by ELISA (25) . Aslan Başbulut et al. reported that the seropositivity rate was 4.1% by ELISA and 3.3% by WB (11) . Correlation between seropositivity with a history of tick exposure was not detected in the same study.
In our study we investigated the Lyme seropositivity in Bolu Province and its districts. According to our WB test results, B. burgdorferi sensu lato seropositivity was detected as 4.6% for IgG and 3.8% for IgM. Our results are compatible with domestic and foreign data. B. burgdorferi sensu lato infection cannot be ignored in this province. Bolu is a province situated in the northwestern region of Turkey. Most of Bolu consists of forests and lakes, which may be a risk for tick exposure. Higher seropositivity rates seen in those living in rural areas, those engaged in agriculture, and people vacationing in rural areas found in this study support this hypothesis. Serological tests are of great importance in the diagnosis of Lyme disease because of people's inability to remember a history of tick exposure, EM lesions cannot always been seen and other clinical symptoms may be confused with other diseases. A limited number of studies have been completed about Lyme disease in Turkey, and the regions where the disease is endemic are not known yet. Detection of endemic regions of Lyme disease with determination of seropositivity rates will increase the awareness among clinicians about this disease. This research determined the seroprevalence of Lyme disease in our region. This study also shed light on other studies to be completed in the future and will contribute to the creation of seroprevalence maps in Turkey.
